Status:
COMPLETED
Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds
Lead Sponsor:
Merz Pharmaceuticals GmbH
Conditions:
Nasolabial Folds
Eligibility:
All Genders
30-60 years
Phase:
PHASE4
Brief Summary
Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.
Eligibility Criteria
Inclusion
- main inclusion criteria: severity rating scale grade 3 or 4
Exclusion
- main exclusion criterion: other nasolabial fold corrections within 6 months prior to study entry
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00429520
Start Date
December 1 2005
End Date
December 1 2006
Last Update
February 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Merz Pharmaceuticals
Frankfurt, Germany, 60318